참고문헌 (36)

1. Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239-57. 

   상세보기

2. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58(3);389-462. 

   상세보기

3. Miller LK, Devi LA. The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev. 2011;63(3):461-70. 

   상세보기

4. Luger TA. Neuromediators--a crucial component of the skin immune system. J Dermatol Sci. 2002;30(2):87-93. 

   상세보기

5. Maccarrone M, Di Rienzo M, Battista N, Gasperi V, Guerrieri P, Rossi A, Finazzi-Agro A. The endocannabinoid system in human keratinocytes: evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase. J Biol Chem. 2003;278(36):33896-903. 

6. Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S. Attenuation of allergic contact dermatitis through the endocannabinoid system. Science. 2007;316(5830):1494-7. 

   상세보기

7. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW, Jorcano JL, Guzman M. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest. 2003;111(1):43-50. 

   상세보기

8. Gaffal E, Cron M, Glodde N, Bald T, Kuner R, Zimmer A, Lutz B, Tuting T. Cannabinoid 1 receptors in keratinocytes modulate proinflammatory chemokine secretion and attenuate contact allergic inflammation. J Immunol. 2013;190(10):4929-36. 

   상세보기

9. Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol. 2005;168:509-54. 

   상세보기

10. Jhaveri MD, Richardson D, Chapman V. Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol. 2007;152(5):624-32. 

    상세보기

11. Toth BI, Dobrosi N, Dajnoki A, Czifra G, Olah A, Szollosi AG, Juhasz I, Sugawara K, Paus R, Biro T. Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1. J Invest Dermatol. 2011;131(5):1095-104. 

    상세보기

12. Toth KF, Adam D, Biro T, Olah A. Cannabinoid signaling in the skin: therapeutic potential of the "C(ut)annabinoid" system. Molecules. 2019;24(5):918. 

    상세보기

13. Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allegology International. 2018;67(1):3-11. 

14. Takei K, Mitoma C, Hashimoto-Hachiya A, Takahara M, Tsuji G, Nakahara T, Furue M. Galactomyces fermentation filtrate prevents T helper2-mediated reduction of filaggrin in an aryl hydrocarbon receptor-dependent manner. Clin Exp Dermatol. 2015;40(7):786-93. 

    상세보기

15. Takei K, Mitoma C, Hashimoto-Hachiya A, Uchi H, Takahara M, Tsuji G, Kido Nakahara M, Nakahara T, Furue M. Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor. J Dermatol. 2015;42(2):171-80. 

    상세보기

16. Tenn MW, Ellis AK. The clinical relevance of filaggrin mutations: effect on allergic disease. Ann Allergy Asthma Immunol. 2016;117(5):483-9. 

17. The textbook compilation committee of Korean herbology. Bonchohak. 1st ed. Seoul. Younglimsa. 2010:218-20. 

18. Park WS. Effect of Scutellariae radix water extract on hydrogen peroxide production in RAW 264.7 mouse macrophages. Kor. J. Herbology. 2011;26(1):53-8. 

19. Yang BD, Kim SR, Choi CH, Jeoung HW, Kim HW. Effects of Scutellaria baicalensis extract on skin lesion of contact dermatitis induced by DNFB in Mice. J Physiol & Pathol Korean Med. 2017;31(1):59-64. 

20. Kim YH, Park YS. Effect of Scutellaria baicalensis water extract on antioxidative activity and epidermal thickness in DNCB-induced allergic contact dermatitis animal model. Korean Soc Food Sci Nutr. 2006;35(5):543-8. 

21. Kim BA, Kim MS, Kang BM, Byeon SH, Park IH, Park JH, Jung JW, Ahn EM, Jung HA, Jang JH, Bae W, Lee HY, Choi PN, Park CI. Inhibitory studies of Hwangryunhaedok-tang on development of atopic dermatitis in NC/Nga mice. Kor. J. Herbology. 2008;23(2):59-65. 

22. Ahn SH, Kim KB. Effect of anti-inflammation through creation of skin fat barrier on Scutellaria baicalensis extract. J Pediatr Korean Med. 2021;35(1):40-7. 

23. Jun JH, Kang YH. The effects of Scutellaria baicalensis GEORGI on allergic contact dermatitis induced by DNCB in mice. D.J.I.O.M. 1998;7(1):119-33. 

24. Joo KM, Hwang JH, Bae SJ, Nahm DH, Park HS, Ye YM, Lim KM. Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins. J Dermatol Sci. 2015;77(1):71-4. 

    상세보기

25. Jung BG, Cho SJ, Ko JH, Lee BJ. Inhibitory effects of interleukin-10 plasmid DNA on the development of atopic dermatitis-like skin lesions in NC/Nga mice. J Vet Sci. 2010;11(3):213-20. 

    상세보기

26. Amin K. The role of mast cells in allergic inflammation. Respir. Med. 2012;106(1):9-14. 

    상세보기

27. Cha HY, Ahn SH, Cheon JH, Park IS, Kim JT, Kim KB. Hataedock treatment has preventive therapeutic effects in atopic dermatitis-induced NC/Nga mice under high-fat diet conditions. Evid Based Complement Alternat Med. 2016;2016:1739760 

    상세보기

28. Woessner JF Jr. MMPs and TIMPs-an historical perspective. Mol Biotechnol. 2002;22(1):33-49. 

    상세보기

29. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006;11(1):529-43. 

    상세보기

30. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblast of rheumatoid arthritis. J Biol Chem. 2000;275(1):444-50 

31. Salzet M. Invertebrate molecular neuroimmune processes. Brain Res Rev, 2000;34(1):69-79. 

32. Yang H, Zhou J, Lehmann C. GPR55-a putative "type 3" cannabinoid receptor in inflammation. J Basic Clin Physiol Pharmacol. 2016;27(3):297-302. 

33. Nam GW, Jeong SK, Park BM, Lee SH, Kim HJ, Hong SP, Kim BJ, Kim BW. Selective cannabinoid receptor-1 agonists regulate mast cell activation in an oxazolone-induced atopic dermatitis model. Ann Dermatol, 2016;28(1):22-9. 

    상세보기

34. Kim HJ, Kim B, Park BM, Jeon JE, Lee SH, Mann S, Ahn SK, Hong SP, Jeong SK. Topical cannabinoid receptor 1 agonist attenuates the cutaneous inflammatory responses in oxazolone-induced atopic dermatitis model. Int J Dermatol. 2015;54(10):401-8. 

35. Haruna T, Soga M, Morioka Y, Imura K, Furue Y, Yamamoto M, Hayakawa J, Deguchi M, Arimura A, Yasui K. The inhibitory effect of S-777469, a cannabinoid type 2 receptor agonist, on skin inflammation in mice. Pharmacology. 2017;99(5-6):259-67. 

36. Cantarella G, Scollo M, Lempereur L, Saccani-Jotti G, Basile F, Bernardini R. Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells. Biochem Pharmacol. 2011;82(4):380-8. 

    상세보기

저자의 다른 논문 :

김기봉 (96)